NCT02162836 2020-04-27A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate CancerJanssen Pharmaceutical K.K.Phase 1 Completed6 enrolled
NCT01351688 2013-07-03An Open Label Prostate Cancer Study in Japanese PatientsAstraZenecaPhase 1 Completed13 enrolled